The efficacy and safety of XELOX plus bevacizumab with oxaliplatin stop-and-go strategy in first-line treatment for metastatic colorectal cancer: CCOG 0902 study.
Takuya Watanabe
No relevant relationships to disclose
Goro Nakayama
No relevant relationships to disclose
Kiyoshi Ishigure
No relevant relationships to disclose
Naomi Hayashi
No relevant relationships to disclose
Toyohisa Yaguchi
No relevant relationships to disclose
Hiroshi Kojima
No relevant relationships to disclose
Kenji Tsuboi
No relevant relationships to disclose
Akihiro Ito
No relevant relationships to disclose
Tomohiro Deguchi
No relevant relationships to disclose
Masanori Sekiya
No relevant relationships to disclose
Chie Tanaka
No relevant relationships to disclose
Yuichi Ando
No relevant relationships to disclose
Norifumi Ohashi
No relevant relationships to disclose
Yasuhiro Kodera
No relevant relationships to disclose